kevision.in

One-line Overview

kevision.in is an India-based SaaS provider. Its “Pharmaceutical Serialization and Track & Trace System” is a serialization solution designed for the pharmaceutical industry, mainly used to meet regulatory requirements for drug traceability and anti-diversion across different markets. Some companies choose it because of its strong experience in the Indian pharmaceutical market, where it can help drug manufacturers quickly build a traceability chain from production to distribution—especially for small and medium-sized pharma companies that want to start a serialization project at a relatively low cost.

Business Details

kevision.in’s core business is serialization software for the pharmaceutical industry, covering online print inspection such as QR codes and barcodes, product tracking and tracing, data aggregation, and regulatory reporting. Founded in India, the company mainly serves pharmaceutical manufacturers in India and nearby countries, including API manufacturers, formulation producers, and contract manufacturing organizations (CMOs). Its system supports integration with regulatory platforms such as India’s DAVA (Drug Authentication and Verification Application), as well as some international standards. In terms of market position, kevision.in is a regional player with a certain reputation in the Indian domestic market, but its global visibility and market share are lower than leading vendors in Europe and the United States. The system uses a modular architecture, allowing customers to select functional components as needed and reduce upfront investment.

Who It’s For

This system is best suited to small and medium-sized pharmaceutical companies in India and Southeast Asia, especially those that need to quickly meet local serialization regulations but have limited budgets. For Chinese pharmaceutical companies, it may also be worth considering if their products are exported to India or Southeast Asia and need to connect with local traceability systems. It is not ideal for large multinational pharmaceutical companies, as its functional depth, global multi-site deployment capabilities, and regulatory coverage may not be sufficient for complex requirements. Pure trading companies or non-pharmaceutical businesses do not need to consider this product.

Key Features and Highlights

• Online print inspection: Supports real-time printing and verification of serialization codes on pharmaceutical packaging, such as 1D barcodes and QR codes, ensuring code quality meets standards and reducing production interruptions.
• Track and trace: Records product movement data across production, packaging, distribution, and end sales, enabling traceability for anti-diversion and recall management.
• Data aggregation and reporting: Supports the association and aggregation of serial numbers across packaging levels, such as cartons and pallets, and can generate electronic reports that meet regulatory requirements for upload to designated platforms.
• Modular deployment: Customers can choose different functional modules based on their own workflows, such as printing, verification, and traceability, without purchasing the full system upfront, reducing initial costs.
• Localized compliance support: Designed especially for India’s DAVA regulations, enabling faster adaptation to Indian regulatory requirements and reducing the burden of custom integration.

Pricing Analysis

Because kevision.in does not publicly disclose monthly or annual fees, it is not possible to directly determine its pricing tier. Based on market pricing for similar India-based serialization SaaS products, it is likely positioned at a mid-to-low price level, mainly targeting budget-sensitive small and medium-sized pharmaceutical companies. Potential hidden costs may include initial deployment fees, customization fees for functional modules, interface fees for connecting to regulatory platforms, and overage charges for later data storage or API calls. Users are advised to contact the official team for a detailed quote and confirm whether future maintenance and upgrade fees are included. Compared with European and US competitors such as TraceLink and SAP ATTP, it has a clear price advantage, but its feature completeness and global support capabilities are correspondingly weaker.

How Chinese Users Can Use It

Accessing kevision.in from China may involve network barriers, and users may need a proxy or VPN to log in to the management dashboard or use online functions normally. In terms of payment methods, there is no public information available, but Indian SaaS services typically support credit cards, PayPal, or international wire transfers. For Chinese users, Alipay or WeChat Pay is likely not supported, so an international credit card or a third-party cross-border payment channel may be needed. In addition, the service cannot issue VAT invoices that comply with Chinese requirements, so enterprise users should consider reimbursement and accounting issues. Domestic alternatives include “爱创科技” and “药链圈”, which support China’s drug traceability standards and can be used without a proxy.

Pros and Cons

Pros:

• ✅ Strong fit for regulatory requirements in India and Southeast Asia, with good localized support
• ✅ Modular design lowers the entry barrier for small and medium-sized enterprises
• ✅ Provides online print inspection with relatively strong production-line integration
• ✅ More competitively priced than European and US competitors
• ✅ Focused on the pharmaceutical industry, with relatively deep industry experience

Cons:

• ❌ Chinese users need a proxy, and latency or instability may affect the experience
• ❌ Does not support Chinese tax invoices, making reimbursement difficult
• ❌ Limited global multi-site and multi-regulation coverage, making it unsuitable for large multinational pharma companies
• ❌ No clear refund policy, with limited transparency around after-sales protection
• ❌ Detailed pricing is not publicly available, and additional customization fees may apply

Comparison with Similar Products

• TraceLink: A leading global serialization platform that supports regulations in multiple countries and offers comprehensive functionality, but at a high price. kevision.in has advantages in pricing and India localization, but is far weaker in global deployment capability.
• SAP ATTP: SAP’s serialization solution, deeply integrated with SAP systems and suitable for large enterprises already using SAP. kevision.in is more independent and better suited to small and medium-sized enterprises without complex ERP systems.
• Domestic Chinese products such as 爱创科技: Focus on China’s drug traceability standards, require no proxy, and support RMB payments and invoices. kevision.in is more suitable for Chinese pharmaceutical companies with export business to India; otherwise, it is generally not recommended.

Recommendation

kevision.in’s pharmaceutical serialization system is best suited for the following scenarios: Chinese pharmaceutical companies whose products are exported to India or Southeast Asia and need to implement serialization traceability under local regulations; or small and medium-sized pharmaceutical manufacturers in India that want to launch a compliance project at a relatively low cost. It is not suitable for Chinese pharma companies that only sell domestically, as there are more compliant local alternatives; large enterprises that require unified global multi-site deployment; or users with strict requirements for after-sales guarantees and refund policies. Interested users are advised to contact the official team first for a demo or trial account, focusing on testing network stability, whether the features meet production-line requirements, and confirming the total cost including hidden fees before deciding whether to pay.